NCT06606197|Completed
Hepatitis C Prevalence in Men Who Have Sex With Men
CRIBADO DE VIRUS DE LA HEPATITIS C en Hombres Que Tienen Sexo Con Hombres (HSH) Sitges
Loading search results
CRIBADO DE VIRUS DE LA HEPATITIS C en Hombres Que Tienen Sexo Con Hombres (HSH) Sitges
Sponsor study identifier
observational
454
1 country
1
Study Start
September 9, 2022
Actual (reported)Primary Completion
September 11, 2022
Actual (reported)Study Completion
September 11, 2022
Actual (reported)This is an observational study aimed at determining the prevalence of hepatitis C in a specific population: men who have sex with men.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 11, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 9, 2022
Actual (reported)September 11, 2022
Actual (reported)September 11, 2022
Actual (reported)September 16, 2024
Actual (reported)September 20, 2024
Actual (reported)Number of participants with Hepatitis C screening positive
A positive result will be defined as a positive outcome in both the serological test and the viral load test
Baseline
Having sex with other men
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Population attending the \"International Bears Sitges Week\" festival in September 2022 in Sitges, Barcelona.
Consorci Sanitari Alt Penedès Garraf
Vilafranca del Penedès, Barcelona, 08720, Spain
Albertos S, Majo FX, Esteban R, Colom J, Buti M. A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testing. Front Public Health. 2024 Dec 9;12:1478195. doi: 10.3389/fpubh.2024.1478195. eCollection 2024.
Sonia Albertos, MD
CSAPG
454 participants (actual enrollment reported by the registry).
First Submitted
September 16, 2024
First Posted
September 20, 2024
Study Start
September 9, 2022
Actual (reported)Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population
Contact the study team to confirm eligibility.
Primary Completion
September 11, 2022
Actual (reported)Study Completion
September 11, 2022
Actual (reported)Last Updated
February 12, 2025
Record last verified: 2024-09
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: